Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:bortezomib (250:1 mol/mol) |
PharmacoGx | tanespimycin:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAT | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | INTS8 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | CLIC4 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
mRNA | KHDRBS1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
mRNA | POLR3K | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | RASSF10 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | ANKRD49 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
mRNA | RIC8B | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | GDI2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
mRNA | KCNJ14 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |